|
Glycylcholic acid impurity 3
|
甘氨膽酸雜質(zhì)3
|
15073-99-1
|
|
Glycylcholic acid impurity 2
|
甘氨膽酸雜質(zhì)2
|
70779-06-5
|
|
Glycine impurity 4
|
甘氨酸雜質(zhì)4（D-葡萄糖醛酸）
|
6556-12-3
|
|
Glycopyrrolate EP Impurity N Bromide
|
格隆溴銨EP雜質(zhì)N溴化物
|
58493-54-2
|
|
Pemetrexed Impurity 12
|
培美曲塞雜質(zhì)12
|
155405-81-5
|
|
Glutamic acid
|
谷氨酸
|
56-86-0
|
|
Sodium glutamate
|
谷氨酸鈉
|
142-47-2
|
|
Glutamic acid impurity 4
|
谷氨酸雜質(zhì)4
|
52454-78-1
|
|
Glimepiride EP impurity J
|
格列美脲EP雜質(zhì)J
|
41176-98-1
|
|
Glibenclamide EP Impurity B
|
格列本脲EP雜質(zhì)B
|
21165-77-5
|
|
Gimeracil impurity 1
|
吉美嘧啶雜質(zhì)1
|
149143-68-0
|
|
Gimeracil impurity 3
|
吉美嘧啶雜質(zhì)3
|
1227600-22-7
|
|
Gabapentin EP impurity E
|
加巴噴丁EP雜質(zhì)E
|
67950-95-2
|
|
Galantamine EP impurity D
|
加蘭他敏EP雜質(zhì)D
|
664995-65-7
|
|
Galantamine EP impurity C
|
加蘭他敏EP雜質(zhì)C
|
21133-52-8
|
|
Galantamine EP impurity F
|
加蘭他敏EP雜質(zhì)F
|
60384-53-4
|
|
Galantamine impurity 5
|
加蘭他敏雜質(zhì)5
|
60755-80-8
|
|
Glucosamine sulfate EP impurity B
|
硫酸氨基葡萄糖EP雜質(zhì)B
|
13185-73-4
|
|
Galantamine impurity 6
|
加蘭他敏雜質(zhì)6
|
134332-50-6
|
|
Galantamine EP impurity B
|
加蘭他敏EP雜質(zhì)B
|
1668-85-5
|
|
Galantamine EP impurity A
|
加蘭他敏EP雜質(zhì)A
|
510-77-0
|
|
Gemcitabine impurity C
|
鹽酸吉西他濱EP雜質(zhì)C(尿苷雜質(zhì)6）
|
114248-23-6
|
|
Glimepiride EP impurity D
|
格列美脲EP雜質(zhì)D
|
791104-62-6
|
|
Glimepiride EP impurity C
|
格列美脲EP雜質(zhì)C
|
119018-30-3
|
|
Glimepiride EP impurity B
|
格列美脲EP雜質(zhì)B
|
119018-29-0
|
|
Glimepiride EP impurity E
|
格列美脲EP雜質(zhì)E
|
2366968-77-4
|
|
Glycerol p-hydroxybenzoate
|
對羥基苯甲酸甘油酯（尼莫地平雜質(zhì)3）
|
263552-76-7
|
|
Glimepiride EP impurity I
|
格列美脲EP雜質(zhì)I
|
878480-70-7
|
|
Gemcitabine EP Impurity B
|
鹽酸吉西他濱EP雜質(zhì)B
|
122111-05-1
|
|
Glimepiride impurity 1
|
格列美脲雜質(zhì)1
|
119043-16-2
|
|
Gabapentin EP impurity B
|
加巴噴丁EP雜質(zhì)B
|
133481-09-1
|
|
Gabapentin EP impurity A
|
加巴噴丁EP雜質(zhì)A
|
64744-50-9
|
|
Iohexol EP Impurity H
|
碘海醇EP雜質(zhì)H
|
1651211-79-8
|
|
(αR,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-Methyl-1H-1,2,4-triazole-1-butanaMide
|
艾沙康唑中間體6
|
241479-75-4
|
|
Glycine, N-[(1,1-diMethylethoxy)carbonyl]-N-Methyl-, [2-[[(1-chloroethoxy)carbonyl]MethylaMino]-3-pyridinyl]Methyl ester
|
艾沙康唑側(cè)鏈中間體C1
|
338990-31-1
|
|
Glufosinate impurity 1
|
草銨膦雜質(zhì)1
|
73634-73-8
|
|
Ibuprofen Impurity 66
|
布洛芬雜質(zhì)66
|
67381-50-4
|
|
Iohexol EP Impurity D
|
碘海醇EP雜質(zhì)D
|
157739-09-8
|
|
Glucosamine sulfate EP impurity C
|
硫酸氨基葡萄糖EP雜質(zhì)C
|
17460-13-8
|
|
Gimeracil impurity 4
|
吉美嘧啶雜質(zhì)4
|
149143-67-9
|
|
Ibuprofen Impurity 67
|
布洛芬雜質(zhì)67
|
1314907-71-5
|
|
Iohexol (Iodixanol EP Impurity A)
|
碘海醇(碘克沙醇EP雜質(zhì)A)
|
66108-95-0
|
|
Glycopyrrolate Related Compound I
|
格隆溴銨相關(guān)化合物I
|
1404453-68-4
|
|
Gefitinib EP Impurity A
|
吉非替尼EP雜質(zhì)A
|
199327-61-2
|
|
Glucose impurity 11
|
葡萄糖雜質(zhì)11
|
10257-28-0
|
|
Gefitinib N-Oxide
|
吉非替尼 N-氧化物（吉非替尼雜質(zhì)53）
|
847949-51-3
|
|
Gefitinib Impurity 70
|
吉非替尼雜質(zhì)70
|
199327-59-8
|
|
Gefitinib Impurity 36
|
吉非替尼雜質(zhì)36
|
861453-11-4
|
|
Gefitinib Impurity 71
|
吉非替尼雜質(zhì)71
|
72235-56-4
|
|
Gefitinib Impurity 1
|
吉非替尼雜質(zhì)1
|
1561173-24-7
|
|
Gefitinib Impurity 7
|
吉非替尼雜質(zhì)7
|
1608115-59-8
|
|
Gefitinib Impurity H
|
吉非替尼雜質(zhì)H
|
847949-49-9
|
|
Gefitinib EP Impurity B
|
吉非替尼EP雜質(zhì)B
|
1603814-04-5
|
|
Gluon Bromide EP Impurity G
|
格隆溴銨EP雜質(zhì)G
|
13118-11-1
|
|
Gluon ammonium bromide impurity 1
|
格隆溴銨雜質(zhì)1
|
201667-20-1
|
|
Glycopyrrolate Impurity 27
|
格隆溴銨雜質(zhì)27
|
7505-92-2
|
|
Isavuconazole Impurity 49
|
艾沙康唑雜質(zhì)49
|
2761502-58-1
|
|
Ilaprazole Impurity 40
|
艾普拉唑雜質(zhì)40
|
22876-21-7
|
|
Ilaprazole Intermediate 3
|
艾普拉唑中間體3
|
2818-66-8
|
|
Isoproterenol Impurity 6
|
異丙腎上腺素雜質(zhì)6
|
2714437-16-6
|
|
Isoproterenol Impurity 2
|
異丙腎上腺素雜質(zhì)2
|
28177-45-9
|
|
Ilaprazole Impurity 31
|
艾普拉唑雜質(zhì)31
|
1360824-56-1
|
|
Isoproterenol Impurity 28
|
異丙腎上腺素雜質(zhì)28
|
98496-30-1
|
|
Indapamide Impurity 21
|
吲達(dá)帕胺雜質(zhì)21
|
70049-77-3
|
|
Indapamide Impurity E
|
吲達(dá)帕胺雜質(zhì)E
|
122-01-0
|
|
Indapamide Impurity G
|
吲達(dá)帕胺雜質(zhì)G
|
55-18-5
|
|
Isoflurane EP Impurity B
|
異氟醚EP雜質(zhì)B
|
1885-48-9
|
|
Ixazomib citrate (USAN)
|
伊沙佐米
|
1239908-20-3
|
|
Istradefylline
|
伊曲茶堿
|
155270-99-8
|
|
Imipenem
|
亞胺培南
|
64221-86-9
|
|
Imipenem Monohydrate
|
亞胺培南一水合物
|
74431-23-5
|
|
Ixazomib Impurity 17
|
艾沙佐米雜質(zhì)17
|
349086-08-4
|
|
Iodomethane
|
碘甲烷
|
74-88-4
|
|
Ixazomib Impurity 8
|
艾沙佐米雜質(zhì)8
|
1378314-08-9
|
|
Imipenem EP Impurity A
|
亞胺培南EP雜質(zhì)A
|
59995-64-1
|
|
Imipenem EP Impurity B
|
亞胺培南EP雜質(zhì)B
|
1197869-90-1
|
|
Ixaconazole side chain intermediate 2
|
艾沙康唑側(cè)鏈中間體2
|
1180002-01-0
|
|
Esaconazole impurity 31
|
艾莎康唑雜質(zhì)31
|
2734004-61-4
|
|
Ixaconazole Impurity31
|
艾沙康唑雜質(zhì)31
|
40805-50-3
|
|
Isavuconazole Impurity 59
|
艾沙康唑雜質(zhì)59
|
21661-87-0
|
|
Ixaconazole side chain intermediate 3
|
艾沙康唑側(cè)鏈中間體3（2-溴-4'-氰基苯乙酮）
|
20099-89-2
|
|
Imipenem Impurity 4
|
亞胺培南雜質(zhì)4
|
74288-40-7
|
|
Itaconic Acid
|
衣康酸
|
97-65-4
|
|
Ilaprazole Impurity 7
|
艾普拉唑雜質(zhì)7
|
1360824-57-2
|
|
Ilaprazole Impurity 9
|
艾普拉唑雜質(zhì)9
|
6325-91-3
|
|
Ilaprazole Impurity 22
|
艾普拉唑雜質(zhì)22
|
2285346-39-4
|
|
Ilaprazole Impurity 24
|
艾普拉唑雜質(zhì)24
|
172152-37-3
|
|
Isavuconazole Impurity 96
|
艾沙康唑雜質(zhì)96（分離雜質(zhì)）
|
192225-36-8
|
|
N-propyl p-hydroxybenzoate
|
對羥基苯甲酸正丙酯（尼泊金丙酯）
|
94-13-3
|
|
Ixaconazole chloride
|
艾沙康唑氯化物
|
497235-79-7
|
|
Indapamide Impurity 9
|
吲達(dá)帕胺雜質(zhì)9
|
1219174-77-2
|
|
Ilaprazole Impurity 27
|
艾普拉唑雜質(zhì)27
|
1298015-58-3
|
|
Isavuconazole interMediate 7
|
艾沙康唑中間體7
|
241479-74-3
|
|
Heparin sodium
|
肝素鈉
|
9041-08-1
|
|
Isoproterenol Impurity 4
|
異丙腎上腺素雜質(zhì)4
|
74710-16-0
|
|
Ilaprazole Impurity 21
|
艾普拉唑雜質(zhì)21
|
2285346-38-3
|
|
Ilaprazole Impurity 33
|
艾普拉唑雜質(zhì)33
|
172152-43-1
|
|
Ilaprazole Impurity 23
|
艾普拉唑雜質(zhì)23
|
2285346-40-7
|
|
Isavuconazole Impurity 11
|
艾沙康唑雜質(zhì)11
|
2732924-99-9
|
|
Galantamine EP impurity E
|
加蘭他敏EP雜質(zhì)E
|
41303-74-6
|